Bio-matrix Scientific Group Inc (BMSN) financial statements (2021 and earlier)

Company profile

Business Address 1206 EAST WARNER ROAD, SUITE 101-I
GILBERT, AZ 85296
State of Incorp. DE
Fiscal Year End July 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2021
TTM
7/31/2020
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000
Cash and cash equivalents0000
Short-term investments00  
Receivables  0 
Prepaid expense0000
Other undisclosed current assets  00
Total current assets:0000
Noncurrent Assets
Intangible assets, net (including goodwill), including:00  
Other undisclosed intangible assets, net (including goodwill)00  
Other undisclosed noncurrent assets3000
Total noncurrent assets:3000
TOTAL ASSETS:3000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0021
Accounts payable0000
Accrued liabilities  00
Employee-related liabilities  11
Interest and dividends payable  00
Debt 001
Deferred compensation liability00  
Due to related parties  00
Other undisclosed current liabilities1 00
Total current liabilities:1022
Noncurrent Liabilities
Long-term debt and lease obligation0 0 
Long-term debt, excluding current maturities0 0 
Other undisclosed noncurrent liabilities1   
Total noncurrent liabilities:1 0 
Total liabilities:2032
Stockholders' equity
Stockholders' equity attributable to parent, including:1(0)(3)(2)
Preferred stock0000
Common stock0010
Additional paid in capital313629
Accumulated other comprehensive loss  (0)(0)
Accumulated deficit(2)(1)(40)(32)
Other additional capital  11
Other undisclosed stockholders' equity attributable to parent(0)(1)  
Stockholders' equity attributable to noncontrolling interest  00
Other undisclosed stockholders' equity  (0)0
Total stockholders' equity:1(0)(2)(2)
TOTAL LIABILITIES AND EQUITY:3000

Income statement (P&L) ($ in millions)

1/31/2021
TTM
7/31/2020
9/30/2016
9/30/2015
Revenues  00
Cost of revenue  (1)(1)
Gross profit:  (1)(0)
Operating expenses(1) (2)(2)
Operating loss:(1) (3)(2)
Nonoperating income
(Investment Income, Nonoperating)
  0 
Interest and debt expense(0) (0)(0)
Net loss:(1) (3)(2)
Net loss attributable to noncontrolling interest  (7)(9)
Other undisclosed net income (loss) attributable to parent0  (43)
Net loss attributable to parent:(1) (10)(54)
Other undisclosed net income available to common stockholders, basic   9
Net loss available to common stockholders, diluted:(1) (10)(45)

Comprehensive Income ($ in millions)

1/31/2021
TTM
7/31/2020
9/30/2016
9/30/2015
Net loss:(1) (3)(2)
Comprehensive loss:(1) (3)(2)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (5)(11)
Comprehensive loss, net of tax, attributable to parent:(1) (9)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: